AI for Pharma & Healthcare 2025

CardioNet Monitored 300,000th patient by MCOT(TM)

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Philips, Masimo Extend Partnership to Sensor...

Philips and Masimo have gone on to renew their...

Renovo from China Raises $67M Series...

Ronovo Surgical from China has gone on to close...

NHS Boards to Explore Joint Working...

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients...

The NHS in England has remained under relentless pressure...

CardioNet, Inc. monitored 300,000th patient with the Company's Mobile Cardiac Outpatient Telemetry (MCOT(TM)) service. MCOT is the first system to provide real-time wireless ECG monitoring and 24/7/365 analysis and response.

Randy Thurman, CardioNet Chairman, President and CEO, commented, "With 300,000 patients having now benefited from our MCOT service, it is evident that an increasing number of physicians view real-time, 24/7 monitoring of cardiac arrhythmias as crucial to identifying and preventing life-threatening cardiac-related events such as stroke. The continued availability and adoption of MCOT also brings value to the entire healthcare continuum as it enables physicians to manage arrhythmias before they manifest into more severe conditions that demand significantly greater costs and resources to treat.".

Dr. Paul Schweitzer, Director of Cardiac Arrhythmia Service at Beth Israel Medical Center and Asst. Chief of Cardiology at Albert Einstein College of Medicine in New York City treated the 300,000th MCOT patient.

"The ability to immediately detect a cardiac arrhythmia and then closely monitor the patient for repeat occurrences provides numerous treatment advantages, not the least of which is giving the cardiologist an opportunity to address the condition before it causes a more severe, potentially irreparable outcome," said Dr. Schweitzer. "Through its beat-by-beat wireless monitoring, MCOT provides assurance that these sometimes difficult to detect irregularities will be diagnosed in a manner that allows the physician to understand the root cause and prescribe a course of action for the patient's individual needs."

About CardioNet

CardioNet is the leading provider of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. CardioNet's initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, with a solution that it markets as Mobile Cardiac Outpatient Telemetry(TM) (MCOT(TM)).

For more information, visit www.cardionet.com .

Latest stories

Related stories

Philips, Masimo Extend Partnership to Sensor Technologies

Philips and Masimo have gone on to renew their...

Renovo from China Raises $67M Series D Funding by JJDC

Ronovo Surgical from China has gone on to close...

NHS Boards to Explore Joint Working in Sussex and Surrey

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients Volume Grows

The NHS in England has remained under relentless pressure...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »